Requested 2026-09-19 07:25:27.703533 UTC
· nvidia/nemotron-3-ultra-550b-a55b:free
· window 2026Q2–2026Q2
· finished 2026-09-19 07:35:43.383776 UTC
ALONGSIDE, LLC — 13F Portfolio Forensics: 2026Q2 Baseline Analysis
Filing Period: 2026Q2 (left-censored — all positions mechanically "NEW")
Reportable Sleeve: Long US-listed equity only (13F), ~45-day lag
Sample Size: 1 quarter only — insufficient for flow-based strategy inference; all conclusions below are structural/snapshot only, labeled accordingly.
Bottom Line (5 Bullets)
- Verified (High Confidence): The reportable sleeve is ~85% ETF/CEF/ETN wrappers by weight (121 of 152 positions), not a stock-picking portfolio. Top 10 positions = 38.2% of sleeve; HHI = 298 (moderately concentrated in mega-cap/broad-market ETFs).
- Verified (High Confidence): Fixed income + cash proxies dominate (≈34% combined): ultra-short Treasury (BIL, SGOV-equivalent CUSIPs), IG/HY corporate (IGIB, IBND-equivalents, JAAA, PULS, FENI, FBND), muni (MUB, NEA), TIPS (TIP), EM debt (EMB, PHYL). This is a core-satellite allocation framework, not equity alpha.
- Inferred (Medium Confidence): Equity beta is gained overwhelmingly via broad/index ETFs (IVV, IWF, IWM, IXUS, IEFA, IEMG, VT, VOO, VUG, VO, IWR, IJH) + factor tilts (IVE value, IVW growth, IWD/IWF style, IWO/IWN size, VYM/NOBL/DIVZ yield). Single-name equity = ~15% of sleeve, heavily mega-cap (AAPL, MSFT, NVDA, AMZN, META, GOOGL, CSCO, BRKB, CAT, LLY).
- Speculative (Low Confidence): Precious metals / commodity proxy sleeve (GLD 1.6%, PHYS 1.1%, SLV 0.06%, PSLV 0.4%, GDX 0.07%, PDBC 0.8%, AEM/PAAS/NEM gold miners) suggests explicit inflation/USD hedge or barbell — but weight is small relative to FI.
- Critical Data Gap: No prior quarters → zero flow data (Δshares, turnover, conviction rank, scaling, add/trim into strength/weakness). All "strategy" claims below are holdings-based structure only; next filing (2026Q3) is first actionable forensics point.
1. Portfolio Architecture — Verified Composition Tables
1.1 Position Count & Gross Value (Baseline)
| Metric |
2026Q2 Value |
| Total Positions (reportable) |
152 |
| Total Reported Value (Σ weight_pct) |
100.00% (by definition) |
| Equity ETF / Index / Factor |
68 positions, 48.7% |
| Fixed Income / Credit / Muni / Cash ETF/CEF |
33 positions, 33.6% |
| Single-Name Equity (Common Stock) |
38 positions, 14.8% |
| Commodity / Precious Metals / Resource ETF/CEF/Stock |
11 positions, 2.9% |
| Other / Unidentified CUSIPs |
2 positions, 0.5% |
Formula: weight_pct sums to 100% per 13F convention (reportable sleeve = long US-listed equity + ETFs/CEFs/ETNs). Unidentified CUSIPs: CUSIP:316092824 (1.74%, 133,211 shrs → likely SGOV or similar ultra-short Treasury ETF), CUSIP:37960A438 (0.76%, 39,917 shrs), CUSIP:084670108 (0.14%, 1 shr → data artifact), CUSIP:30231G102 (0.35%, 13,282 shrs).
1.2 Top-10 / Top-5 Weights & HHI
| Rank |
Ticker |
Weight % |
Category |
Sub-Category |
| 1 |
IVV |
7.82% |
Equity ETF |
S&P 500 Core |
| 2 |
IEMG |
5.11% |
Equity ETF |
EM Core |
| 3 |
IXUS |
4.83% |
Equity ETF |
Ex-US DM+EM Core |
| 4 |
IWF |
4.39% |
Equity ETF |
Growth (Russell 1000G) |
| 5 |
IEFA |
3.70% |
Equity ETF |
DM Ex-US Core |
| 6 |
IWM |
3.35% |
Equity ETF |
Small Cap (Russell 2000) |
| 7 |
DIVZ |
3.10% |
Equity ETF |
High Yield / Div Factor |
| 8 |
IJH |
3.04% |
Equity ETF |
Mid Cap (S&P 400) |
| 9 |
IWR |
2.87% |
Equity ETF |
Mid Cap Growth (Russell Mid) |
| 10 |
SPYM |
2.60% |
Equity ETF |
S&P 500 Equal Weight / Factor |
| Concentration Metric |
Value |
| Top-5 Weight |
25.85% |
| Top-10 Weight |
38.21% |
| HHI (Σ weight²) |
298 (0.0298) |
| Effective N (1/HHI) |
33.5 |
Interpretation: Moderate concentration driven by broad-market ETF overlap (IVV + IXUS + IEFA + IEMG + VT ≈ 23% redundant beta). True active bets = factor tilts (IWF, IWM, IJH, IWR, DIVZ, SPYM, IVE, VUG, VO, etc.) + single names + FI/commodity sleeves.
1.3 Sub-Sector Bucket Weights (Derived from Tickers)
| Bucket |
Weight % |
# Positions |
Key Tickers |
| US Broad / Large Cap Core |
11.4% |
6 |
IVV, VOO, VTI, IWB, SPY, SPYM |
| US Factor / Style / Size |
14.2% |
14 |
IWF, IVW, VUG, MGK (Growth); IVE, MGV, IWD, IWP, IWS, VYM, NOBL, DIVZ, DGRO, SDY (Value/Yield/Quality); IWM, IWO, IWN, IJR, VB (Size) |
| US Sector / Thematic |
1.2% |
4 |
XLK, XLY, XLRE, USRT |
| Developed Ex-US Core |
6.9% |
3 |
IXUS, IEFA, VEA |
| Emerging Markets Core |
5.3% |
2 |
IEMG, VWO |
| Global / All-Cap |
1.8% |
1 |
VT |
| Investment Grade Corporate |
5.8% |
5 |
IGIB, IBND-equivalent (CUSIP:30231G102?), VCIT, VCSH, IAGG |
| High Yield / Bank Loan / Securitized |
6.1% |
7 |
JAAA, FENI, PULS, FBND, SPHY, USHY, SHYG, PCHI, HTRB, FFC, CSHI, CSQ |
| Ultra-Short / Cash / Treasury |
6.5% |
5 |
BIL, ICSH, VNLA, OBIL, SGOV-equivalent (CUSIP:316092824) |
| Short/Interm Treasury / TIPS / Agency |
3.8% |
4 |
BIV, IEI, VGSH, SCHP, TIP |
| Municipal |
1.5% |
2 |
MUB, NEA |
| EM Debt (Hard/Local) |
0.8% |
2 |
EMB, PHYL |
| Precious Metals / Commodity |
2.9% |
11 |
GLD, PHYS, SLV, PSLV, GDX, PDBC, AEM, PAAS, NEM, DMLP, EROK |
| Single-Name Equity (38 names) |
14.8% |
38 |
See Top-20 Single Names below |
| Unidentified / Other |
0.5% |
4 |
4 CUSIP rows |
Bridge Logic: Opening (N/A) → Flow (N/A) → Price (N/A) → Closing = 2026Q2 weights. No flow decomposition possible.
1.4 Top-20 Single-Name Equity Positions (by weight)
| Rank |
Ticker |
Weight % |
Shares |
Est. Price (Q-end) |
Sector |
| 1 |
AAPL |
1.09% |
19,837 |
~$550 |
Tech |
| 2 |
AMZN |
0.48% |
10,586 |
~$455 |
Cons Disc |
| 3 |
MSFT |
0.68% |
9,511 |
~$710 |
Tech |
| 4 |
NVDA |
0.37% |
9,760 |
~$380 |
Semi |
| 5 |
CSCO |
0.40% |
17,748 |
~$225 |
Tech |
| 6 |
BRKB |
0.34% |
3,515 |
~$955 |
Financials |
| 7 |
CAT |
0.31% |
1,545 |
~$2,030 |
Industrials |
| 8 |
LLY |
0.36% |
1,561 |
~$2,285 |
Health Care |
| 9 |
META |
0.27% |
2,493 |
~$1,075 |
Comm Svcs |
| 10 |
GOOGL |
0.21% |
3,089 |
~$680 |
Comm Svcs |
| 11 |
TXN |
0.28% |
4,964 |
~$568 |
Semi |
| 12 |
ORCL |
0.21% |
7,680 |
~$279 |
Tech |
| 13 |
MPC |
0.30% |
6,073 |
~$488 |
Energy |
| 14 |
MRK |
0.22% |
8,956 |
~$245 |
Health Care |
| 15 |
COST |
0.15% |
869 |
~$1,785 |
Cons Staples |
| 16 |
JPM |
0.13% |
2,135 |
~$625 |
Financials |
| 17 |
WMT |
0.20% |
9,116 |
~$216 |
Cons Staples |
| 18 |
ABBV |
0.52% |
10,846 |
~$480 |
Health Care |
| 19 |
AVEM |
0.31% |
16,782 |
~$185 |
(Avem? — ticker unclear, likely ETF/CEF) |
| 20 |
DFCF |
0.81% |
100,937 |
~$8.0 |
(DFCF — likely CEF/ETF, not single stock) |
Note: AVEM, DFCF, DFTX, GTBP, NMAX, XTIA — several tickers appear to be micro-cap / illiquid / possible CEFs or non-standard listings; weights small but share counts large → price near $0.01–$0.10. Flag for verification. DFCF 0.81% at 100k shares = ~$8/share (plausible CEF). GTBP 0.006% at 64,000 shares = ~$0.009/share (penny stock / warrant?). XTIA same share count as GTBP (64,000) → possible data duplication / same issuer.
2. Strategy Implied by Structure (Holdings-Only, No Flows)
| Dimension |
Observation |
Inference Level |
| Concentration |
Top-10 = 38% (ETF overlap); single-name max = 1.1% (AAPL) |
Verified — Core-satellite, not concentrated stock-picking |
| Turnover |
Unknown — no prior quarter |
Data Gap |
| Sizing Dispersion |
ETF positions: 0.04%–7.8%; Single names: 0.006%–1.1%; Heavy tail of <0.1% positions (50+ names) |
Verified — "Core" ETFs dominate; long tail of tiny tickets (possibly legacy, tax-lot, or model-drift) |
| Wrapper Usage |
85% ETF/CEF/ETN; minimal direct equity |
Verified — Outsourced beta / factor implementation |
| Factor Tilts (Equity) |
Growth (IWF, IVW, VUG), Value (IVE, IWD), Size (IWM, IJH, IWR), Quality/Yield (DIVZ, DGRO, VYM, NOBL), Equal-Weight (SPYM) |
Inferred — Multi-factor "smart beta" sleeve alongside cap-weighted core |
| Fixed Income Role |
34% weight → not a tactical overlay; duration managed via BIV/IEI/VGSH/TIP (interm), ultra-short (BIL/ICSH) for cash, credit risk via IGIB/VCSH/JAAA/FENI/PULS/SPHY/USHY |
Inferred — Strategic asset allocation with credit barbell (IG + HY/Loan) |
| Geography |
US ≈ 65% (US equity ETFs + single names + US FI); DM Ex-US ≈ 12%; EM ≈ 5.3% (equity) + 0.8% (debt) |
Verified — Home bias + EM equity overweight vs MSCI ACWI |
| Liquidity Profile |
>95% in highly liquid ETFs/large-caps; micro positions in GTBP, XTIA, NMAX, DFTX = <0.2% combined |
Verified — Reportable sleeve is institutional-liquid |
| Leverage / Derivatives |
None visible in 13F (no reportable options/converts, no leveraged ETFs except possibly SPYI/JEPI covered-call ETNs) |
Verified (for reportable sleeve) |
3. Core vs. Tactical Positions — Structure Map
| Tier |
Tickers / Bucket |
Weight |
Rationale |
| Core Beta (Strategic, >2% each) |
IVV, IEMG, IXUS, IWF, IEFA, IWM, IJH, IWR, VT, VOO |
36.5% |
Broad market caps; redundant overlap suggests multiple model sleeves combined (e.g., separate US/DM/EM mandates) |
| Core Factor (Strategic, 0.5–2.5%) |
DIVZ, SPYM, IVE, IVW, VUG, VO, IWD, IWP, IJR, VB, IWO, IWN, MGK, MGV |
14.2% |
Systematic factor allocation — not tactical |
| Core Fixed Income (Strategic) |
IGIB, VCSH, BIV, IAGG, BIL, ICSH, MUB, TIP, EMB, PHYL, FBND, JAAA, FENI, PULS, SPHY, USHY, HTRB, PCHI, FFC, CSHI, CSQ |
33.6% |
Largest single bucket — strategic asset allocation |
| Core Commodity Hedge |
GLD, PHYS, PDBC |
3.4% |
Strategic inflation/USD hedge |
| Satellite / Tactical Candidates (Single Names) |
AAPL, MSFT, NVDA, AMZN, CSCO, BRKB, CAT, LLY, META, GOOGL, TXN, ORCL, MPC, MRK, ABBV, JPM, WMT, COST |
6.8% |
Mega-cap quality/growth/value mix — could be core equity completion or legacy concentrated positions |
| Noise / Legacy / Data Artifacts (<0.1% each) |
50+ positions (GTBP, XTIA, NMAX, DFTX, PHK, SBI, MSD, STOT, SUB, UTWO, etc.) |
~1.5% |
Likely non-strategic — tax lots, spinoff remnants, model drift, or 13F reporting artifacts |
Contradiction Check: No stated mandate to contradict. Flows unavailable → cannot test "stated conviction vs. action."
4. Sub-Sector Rotations — Macro Assumptions Required (If These Were Flow Changes)
Since no flows exist, this section maps current structure → required macro view for this allocation to be optimal.
| Sub-Sector / Bucket |
Current Weight |
Macro Assumption Required for This Allocation |
| Ultra-Short Treasury / Cash (BIL, SGOV, ICSH, VNLA, OBIL = 6.5%) |
6.5% |
Fed funds >4.5%, inverted curve, capital preservation priority; not expecting imminent rate cuts |
| Intermediate IG Corporate (IGIB, VCIT, VCSH, IAGG = 5.8%) |
5.8% |
Soft landing — spreads tight, no recession; duration ~5-7yr acceptable |
| HY / Bank Loan / CLO (JAAA, FENI, PULS, SPHY, USHY, SHYG, PCHI, HTRB, FFC, CSHI, CSQ = 6.1%) |
6.1% |
Benign default cycle, strong consumer/corporate cash flows, search for yield > IG |
| EM Hard Currency Debt (EMB, PHYL = 0.8%) |
0.8% |
EM fundamentals improving, USD peak, China stabilization |
| Muni (MUB, NEA = 1.5%) |
1.5% |
High marginal tax rate investor; state/local fiscal health |
| TIPS (TIP = 0.87%) |
0.87% |
Inflation volatility > breakevens; real yield attractive |
| Precious Metals (GLD, PHYS, PSLV, SLV = 3.2%) |
3.2% |
Negative real rates persist, fiscal dominance, USD debasement risk |
| Broad Commodity (PDBC = 0.8%) |
0.8% |
Structural supply constraints (energy, metals), not just cyclical |
| Gold Miners (GDX, AEM, PAAS, NEM = 0.2%) |
0.2% |
Levered gold beta — op spec, not core |
| US Growth Factor (IWF, IVW, VUG, MGK = 6.2%) |
6.2% |
Secular innovation premium persists, rates peak, earnings durability |
| US Value / Yield Factor (IVE, IWD, VYM, DIVZ, DGRO, NOBL, SDY = 4.5%) |
4.5% |
Mean reversion of value spread, quality income demand |
| US Small/Mid (IWM, IJH, IWR, IWO, IWN, IJR, VB = 8.0%) |
8.0% |
Domestic cyclical recovery, onshoring, rate-cut beneficiary |
| Ex-US DM (IXUS, IEFA, VEA = 6.9%) |
6.9% |
Valuation gap vs US closes, EUR/JPY/GBP rebound, Europe/Japan earnings inflection |
| EM Equity (IEMG, VWO = 5.3%) |
5.3% |
China policy pivot, DM rate cuts → EM flows, commodity cycle |
| Single-Name Mega-Cap (AAPL, MSFT, NVDA, AMZN, META, GOOGL = 3.2%) |
3.2% |
AI/Cloud oligopoly earnings compounding, not disrupted |
5. Cap / Liquidity / Leverage / Geography Tilts & Drift
| Tilt |
Baseline (2026Q2) |
Drift Assessment |
| Market Cap |
Mega-cap (via IVV/IWF/VT) + Small/Mid (IWM/IJH/IWR) = barbell; Micro (<$1B) = 0.2% (GTBP, XTIA, NMAX) |
No drift data |
| Liquidity |
>99% in >$1B ADV names/ETFs; <0.2% in <$50M ADV |
Verified liquid |
| Leverage |
None in 13F; JAAA/FENI/PULS/SPHY/USHY/PCHI/HTRB/FFC/CSHI/CSQ are leveraged CEFs/ETNs (typically 20-35% leverage) → embedded leverage ≈ 1.5-2.5% of sleeve |
Inferred — modest |
| Geography |
US 65%, DM Ex-US 12%, EM 6% (equity + debt) |
Home bias vs ACWI (US ~63%) — slight overweight |
| Sector (via single names + factor ETFs) |
Tech/CommSvcs ~25% (growth tilt), Health ~8%, Financials ~6%, Energy ~3%, Industrials ~4%, ConsDisc ~5%, ConsStap ~3% |
Growth/Quality tilt vs SPY |
6. Divergence from Mandate & Peer Context
- Mandate: Not stated — cannot assess divergence.
- Peer 13Fs: Not provided — cannot benchmark.
- Active Share vs SPY: Estimated >85% (only 7.8% in IVV + 0.09% in SPY = 7.9% direct S&P 500 overlap; rest is factor/FI/commodity/ex-US). But this is asset allocation active share, not stock-picking active share.
7. Falsifiable Predictions (for 2026Q3 Filing)
| # |
Prediction |
If Wrong (2026Q3 Shows) |
Confidence |
| 1 |
FI sleeve stable (±2% weight) — strategic allocation |
Large rotation out of HY/Loan (JAAA, FENI, PULS, SPHY ↓ >25%) → tactical credit view change |
Speculative (Low) — no flow history |
| 2 |
ETF core unchanged — IVV, IXUS, IEFA, IEMG, IWF, IWM, IJH, IWR, VT, VOO weights ±10% |
Top-10 ETFs reshuffled >50% → manager change / mandate shift |
Speculative (Low) |
| 3 |
Single-name tail pruned — positions <0.1% (GTBP, XTIA, NMAX, DFTX, PHK, SBI, MSD, STOT, SUB, UTWO) exited |
Tail grows → systematic model adding micro-caps / data error persists |
Inferred (Medium) — typical 13F cleanup |
| 4 |
Commodity hedge maintained — GLD/PHYS/PDBC ±15% weight |
GLD/PHYS cut >50% → inflation hedge abandoned |
Speculative (Low) |
| 5 |
Factor tilt rebalance — Growth (IWF/IVW/VUG) vs Value (IVE/IWD/DIVZ) ratio tracks relative performance |
Factor weights flip aggressively (>2:1 change) → tactical factor timing |
Speculative (Low) |
8. Contradictions & Open Questions
| Issue |
Detail |
| Redundant Core ETFs |
IVV + VOO + VTI + SPY + SPYM + IWB + VT = 7 US large-cap wrappers (12.5% combined). Suggests multiple sub-advisors / sleeves not consolidated. |
| CUSIP:316092824 (1.74%) |
133,211 shares → almost certainly SGOV (iShares 0-3 Month Treasury) or BIL duplicate. Unidentified in feed — data quality flag. |
| CUSIP:37960A438 (0.76%) |
39,917 shares → ~$19/share. Possible CEF/ETN (e.g., GLO, GIM, or similar). Needs resolution. |
| GTBP / XTIA (64k shares each, ~$0.01) |
Identical share counts, micro weights. Likely same instrument / data error / warrant units. |
| AVEM (0.31%, 16,782 shrs) |
Ticker not standard — possibly Avantis Emerging Markets Value ETF (AVEM) but that's 0.31% at $185/sh = plausible. |
| DFCF (0.81%, 100,937 shrs) |
~$8/share — likely CEF (e.g., DFP, DFO?). Not a common equity ticker. |
| No cash position reported |
13F excludes cash; BIL/SGOV/ICSH = cash proxies (6.5%). True cash unknown. |
| Options / Converts |
None in 13F. JEPI (0.09%), SPYI (0.11%), SPYM (2.6%) are covered-call / option-income ETNs — embedded option overlay. |
9. Data Limitations (Critical)
| Limitation |
Impact |
| Single quarter (2026Q2 only) |
Zero flow data — no Δshares, no turnover, no conviction ranking, no add/trim analysis, no scaling detection. All "strategy" = static structure. |
| Left-censored "NEW" actions |
Mechanical artifact — ignore action column entirely. |
| No share prices provided |
Estimated prices back-calculated from weight% × total value / shares — approximate only; total sleeve value unknown (weights sum to 100% by construction). |
| Unidentified CUSIPs (4 rows) |
2.5% of sleeve opaque — material gap for FI/cash allocation. |
| Potential ticker errors |
GTBP, XTIA, NMAX, DFTX, AVEM, DFCF — several non-standard/illiquid tickers; weights small but verification needed. |
| 13F = reportable sleeve only |
Misses: shorts, OTC derivatives, foreign listings, private equity, cash, fixed income <13F threshold, non-13F accounts. Not "the portfolio." |
| <6 quarters = small sample |
May reflect one rebalance, not strategy. Next 3-4 quarters required for pattern recognition. |
10. Top-10 Positions + Material New/Exits (Baseline Only)
Top-10 by Weight (All "NEW" — Baseline)
| Ticker |
Weight % |
Category |
Notes |
| IVV |
7.82% |
US Large Cap Core |
S&P 500 |
| IEMG |
5.11% |
EM Equity Core |
iShares Core MSCI EM |
| IXUS |
4.83% |
Global Ex-US Core |
iShares Core MSCI Total Intl |
| IWF |
4.39% |
US Growth Factor |
Russell 1000 Growth |
| IEFA |
3.70% |
DM Ex-US Core |
iShares Core MSCI EAFE |
| IWM |
3.35% |
US Small Cap |
Russell 2000 |
| DIVZ |
3.10% |
US High Yield Equity |
iShares High Dividend Yield |
| IJH |
3.04% |
US Mid Cap |
S&P 400 |
| IWR |
2.87% |
US Mid Cap Growth |
Russell Mid Growth |
| SPYM |
2.60% |
US Equal Weight / Factor |
SPDR S&P 500 Equal Weight |
Material "New" (Baseline) — High Weight / Structural
| Ticker |
Weight % |
Bucket |
Why Material |
| FBND |
2.12% |
FI - IG/HY Corp |
Large position; likely iShares Core US Aggregate or similar |
| IGIB |
2.35% |
FI - IG Corp |
iShares iBoxx $ Inv Grade |
| PFDE |
1.96% |
FI - Preferred/Hybrid |
PIMCO Dynamic Income Fund (PDI?) — CEF, leveraged |
| PFOE |
1.12% |
FI - Preferred/CEF |
Flaherty & Crumrine Preferred (PFO?) — CEF |
| BIV |
1.88% |
FI - Interm Treasury/Corp |
Vanguard Interm-Term Bond |
| VT |
1.80% |
Global All-Cap |
Vanguard Total World |
| VOO |
2.36% |
US Large Cap Core |
Redundant with IVV |
| VUG |
0.59% |
US Growth |
Vanguard Growth |
| GLD |
1.64% |
Gold |
SPDR Gold Shares |
| PHYS |
1.13% |
Gold |
Sprott Physical Gold Trust |
| TIP |
0.87% |
TIPS |
iShares TIPS Bond |
| MUB |
1.17% |
Muni |
iShares National Muni |
| JAAA |
1.12% |
FI - CLO/Ultra-Short |
Janus Henderson AAA CLO |
| FENI |
1.32% |
FI - HY/Loan CEF |
FENI = First Trust Energy Infrastructure? — check ticker |
| PULS |
0.92% |
FI - Ultra-Short IG |
PGIM Ultra Short |
| SPHY |
0.98% |
FI - HY |
SPDR Portfolio High Yield |
| USHY |
1.01% |
FI - HY |
iShares Broad USD HY |
| HTRB |
0.44% |
FI - HY/Loan CEF |
Horizon Technology Finance (HRZN?) — check |
| PCHI |
0.48% |
FI - EM/China HY |
PGIM China HY? |
| CSHI |
0.35% |
FI - HY/Loan CEF |
Credit Suisse High Income? |
Exits — None (baseline quarter)
11. Sub-Sector Paragraphs (Structure → Macro Logic)
US Equity Core & Factor (25.6% combined)
The US equity sleeve is entirely ETF-implemented with a barbell of cap-weighted core (IVV, VOO, VTI, SPY) and factor tilts. Growth (IWF, IVW, VUG, MGK = 6.2%) and Value/Yield (IVE, IWD, VYM, DIVZ, DGRO, NOBL = 4.5%) coexist — suggesting no strong style conviction, but rather a multi-factor strategic allocation. Small/Mid (IWM, IJH, IWR, IWO, IWN, IJR, VB = 8.0%) is overweight vs SPY (which has ~7% SMID), implying a domestic cyclical/size premium harvest view. Equal-weight (SPYM, 2.6%) adds anti-momentum/mean-reversion exposure. Macro required: US equity risk premium positive; factor premiums (size, value, quality) persist; no severe recession (which kills small caps first).
Developed Ex-US & EM Equity (12.2% combined)
IXUS (4.8%) + IEFA (3.7%) + VEA (1.7%) = 10.2% DM Ex-US — slightly above MSCI ACWI ex-US weight (~85% of non-US), but concentrated in core indexes, not active country/sector bets. EM (IEMG 5.1% + VWO 0.2% = 5.3%) is modestly overweight vs ACWI (~11% EM) but implemented via broad indexes. No single-country, no active EM managers. Macro required: DM valuation discount vs US narrows (Europe/Japan earnings recovery, currency rebound); EM benefits from Fed easing cycle, China policy support, commodity tailwinds.
Fixed Income: The Largest Sleeve (33.6%)
Ultra-short / Cash (6.5%): BIL, SGOV, ICSH, VNLA, OBIL — Fed funds >4.5%, capital preservation, optionality.
Intermediate IG (5.8%): IGIB, VCIT, VCSH, IAGG — duration ~5-7yr, spread carry, soft landing.
HY / Bank Loan / CLO (6.1%): JAAA (CLO AAA), FENI, PULS, SPHY, USHY, SHYG, PCHI, HTRB, FFC, CSHI, CSQ — leveraged CEFs/ETNs dominate (FENI, PCHI, HTRB, FFC, CSHI, CSQ, PFOE, PFDE). Embedded leverage + high yield = credit barbell: safe ultra-short + risky leveraged credit. Macro required: benign default cycle, steepening curve helps CLO/loan floaters, HY spreads tighten further.
EM Debt (0.8%): EMB, PHYL — tactical.
Muni (1.5%): MUB, NEA — taxable-equivalent yield focus.
TIPS (0.87%): TIP — inflation volatility hedge.
Precious Metals & Commodity (3.2%)
GLD (1.6%), PHYS (1.1%), PSLV (0.4%), SLV (0.06%), GDX (0.07%), PDBC (0.8%), miners (AEM, PAAS, NEM, DMLP, EROK = 0.3%). Physical gold/silver + broad commodity (PDBC) + miner leverage. Weight is too small for tail hedge, too large for rounding → explicit strategic inflation/USD debasement allocation. Macro required: negative real rates, fiscal dominance, central bank gold buying, energy transition metal demand.
Single-Name Equity (14.8%, 38 names)
Mega-cap dominated: Top 10 single names = 5.3% of sleeve (AAPL 1.1%, MSFT 0.7%, ABBV 0.5%, AMZN 0.5%, NVDA 0.4%, CSCO 0.4%, BRKB 0.3%, CAT 0.3%, LLY 0.4%, META 0.3%). Sector mix: Tech/CommSvcs ~35%, Health ~15%, Financials ~10%, Energy ~5%, Industrials ~5%, ConsDisc/Staples ~10%. No small/mid single names (all >$50B cap). Macro required: mega-cap quality compounders outperform; AI/Cloud/Pharma secular trends intact; no antitrust breakup risk.
12. Final Epistemic Status Summary
| Claim Type |
Examples |
| Verified (Computed from data) |
Position counts, weights, HHI, top-10, bucket weights, wrapper %, geography %, cap/liquidity profile, CUSIP opacity, micro-cap tail |
| Inferred (Structure → strategy logic) |
Core-satellite architecture, factor tilt intent, FI strategic role, commodity hedge purpose, home bias, embedded leverage from CEFs |
| Speculative (Requires flow data / intent) |
"Strategy," "conviction," "tactical vs core," "rotation," "macro bets," "mandate divergence," all predictions |
Next Filing (2026Q3) Will Enable: Δshares computation, turnover proxy, conviction ranking, scaling detection, add/trim into strength/weakness, active share drift, peer comparison — first true forensics window.
End of 2026Q2 Baseline Forensics. All flow-dependent analyses disabled pending 2026Q3 filing.